Structure of the HIV-1 Integrase Catalytic Domain Complexed with an Inhibitor: a Platform for Antiviral Drug Design

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1999 Nov 11

PMID 10557269

Citations 123

Authors

Y Goldgur

R Craigie

G H Cohen

T Fujiwara

T Yoshinaga

T Fujishita

H Sugimoto

T Endo

H Murai

D R Davies

Affiliations

Soon will be listed here.

Abstract

HIV integrase, the enzyme that inserts the viral DNA into the host chromosome, has no mammalian counterpart, making it an attractive target for antiviral drug design. As one of the three enzymes produced by HIV, it can be expected that inhibitors of this enzyme will complement the therapeutic use of HIV protease and reverse transcriptase inhibitors. We have determined the structure of a complex of the HIV-1 integrase core domain with a novel inhibitor, 5ClTEP, 1-(5-chloroindol-3-yl)-3-hydroxy-3-(2H-tetrazol-5-yl)-pro penone, to 2.1-A resolution. The inhibitor binds centrally in the active site of the integrase and makes a number of close contacts with the protein. Only minor changes in the protein accompany inhibitor binding. This inhibitor complex will provide a platform for structure-based design of an additional class of inhibitors for antiviral therapy.

Citing Articles

(Fr) Keissl Crude Extract Inhibits HIV Subtypes and Integrase Drug-Resistant Strains at Different Stages of HIV Replication.

Naidu D, Oduro-Kwateng E, Soliman M, Ndlovu S, Mkhwanazi N Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006004 PMC: 11859181. DOI: 10.3390/ph18020189.

Structural aspects of HIV-1 integrase inhibitors: SAR studies and synthetic strategies.

Barik P, Gupta S, Singh G, Bharti S, Asati V Mol Divers. 2024; .

PMID: 39690291 DOI: 10.1007/s11030-024-11068-4.

Brief Histories of Retroviral Integration Research and Associated International Conferences.

Grandgenett D, Engelman A Viruses. 2024; 16(4).

PMID: 38675945 PMC: 11054761. DOI: 10.3390/v16040604.

Role of diosgenin extracted from L in suppression of HIV-1 replication: An preclinical study.

Rakshit S, More A, Gaikwad S, Seniya C, Gade A, Muley V Heliyon. 2024; 10(2):e24350.

PMID: 38288021 PMC: 10823083. DOI: 10.1016/j.heliyon.2024.e24350.

The Integrase: An Overview of a Key Player Enzyme in the Antiviral Scenario.

Renzi G, Carta F, Supuran C Int J Mol Sci. 2023; 24(15).

PMID: 37569561 PMC: 10419282. DOI: 10.3390/ijms241512187.

References

Dyda F, Hickman A, Jenkins T, Engelman A, Craigie R, Davies D . Crystal structure of the catalytic domain of HIV-1 integrase: similarity to other polynucleotidyl transferases. Science. 1994; 266(5193):1981-6. DOI: 10.1126/science.7801124. View

Jenkins T, Esposito D, Engelman A, Craigie R . Critical contacts between HIV-1 integrase and viral DNA identified by structure-based analysis and photo-crosslinking. EMBO J. 1998; 16(22):6849-59. PMC: 1170288. DOI: 10.1093/emboj/16.22.6849. View

Engelman A, Bushman F, Craigie R . Identification of discrete functional domains of HIV-1 integrase and their organization within an active multimeric complex. EMBO J. 1993; 12(8):3269-75. PMC: 413594. DOI: 10.1002/j.1460-2075.1993.tb05996.x. View

Brunger A, Adams P, Clore G, DeLano W, Gros P, Grosse-Kunstleve R . Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998; 54(Pt 5):905-21. DOI: 10.1107/s0907444998003254. View

Otwinowski Z, Minor W . Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 1997; 276:307-26. DOI: 10.1016/S0076-6879(97)76066-X. View

Lodi P, Ernst J, Kuszewski J, Hickman A, Engelman A, Craigie R . Solution structure of the DNA binding domain of HIV-1 integrase. Biochemistry. 1995; 34(31):9826-33. DOI: 10.1021/bi00031a002. View

Engelman A, Craigie R . Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J Virol. 1992; 66(11):6361-9. PMC: 240128. DOI: 10.1128/JVI.66.11.6361-6369.1992. View

Vandamme A, Van Vaerenbergh K, De Clercq E . Anti-human immunodeficiency virus drug combination strategies. Antivir Chem Chemother. 1999; 9(3):187-203. DOI: 10.1177/095632029800900301. View

Farnet C, Wang B, Lipford J, Bushman F . Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules. Proc Natl Acad Sci U S A. 1996; 93(18):9742-7. PMC: 38499. DOI: 10.1073/pnas.93.18.9742. View

10.

Eijkelenboom A, Lutzke R, Boelens R, Plasterk R, Kaptein R, Hard K . The DNA-binding domain of HIV-1 integrase has an SH3-like fold. Nat Struct Biol. 1995; 2(9):807-10. DOI: 10.1038/nsb0995-807. View

11.

Kulkosky J, Jones K, KATZ R, Mack J, Skalka A . Residues critical for retroviral integrative recombination in a region that is highly conserved among retroviral/retrotransposon integrases and bacterial insertion sequence transposases. Mol Cell Biol. 1992; 12(5):2331-8. PMC: 364405. DOI: 10.1128/mcb.12.5.2331-2338.1992. View

12.

Hazuda D, Blau C, Felock P, Hastings J, Pramanik B, Wolfe A . Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites. Antivir Chem Chemother. 1999; 10(2):63-70. DOI: 10.1177/095632029901000202. View

13.

Maignan S, Guilloteau J, Mikol V . Crystal structures of the catalytic domain of HIV-1 integrase free and complexed with its metal cofactor: high level of similarity of the active site with other viral integrases. J Mol Biol. 1998; 282(2):359-68. DOI: 10.1006/jmbi.1998.2002. View

14.

Goldgur Y, Dyda F, Hickman A, Jenkins T, Craigie R, Davies D . Three new structures of the core domain of HIV-1 integrase: an active site that binds magnesium. Proc Natl Acad Sci U S A. 1998; 95(16):9150-4. PMC: 21307. DOI: 10.1073/pnas.95.16.9150. View

15.

Lubkowski J, Yang F, Alexandratos J, Wlodawer A, Zhao H, Burke Jr T . Structure of the catalytic domain of avian sarcoma virus integrase with a bound HIV-1 integrase-targeted inhibitor. Proc Natl Acad Sci U S A. 1998; 95(9):4831-6. PMC: 20173. DOI: 10.1073/pnas.95.9.4831. View

16.

Scottoline B, Chow S, Ellison V, Brown P . Disruption of the terminal base pairs of retroviral DNA during integration. Genes Dev. 1997; 11(3):371-82. DOI: 10.1101/gad.11.3.371. View

17.

Esposito D, Craigie R . Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction. EMBO J. 1998; 17(19):5832-43. PMC: 1170911. DOI: 10.1093/emboj/17.19.5832. View

18.

Cai M, Zheng R, Caffrey M, Craigie R, Clore G, Gronenborn A . Solution structure of the N-terminal zinc binding domain of HIV-1 integrase. Nat Struct Biol. 1997; 4(7):567-77. DOI: 10.1038/nsb0797-567. View